Aerobic Trainings on Stroke Patients
Effects of Aerobic Interval Exercise Training on Cardiac Fibroblasts and Brain Cells in Stroke Patients
1 other identifier
interventional
23
0 countries
N/A
Brief Summary
Effects of different exercise strategies on stroke patients remain unclear. Randomized controlled trial with concealed allocation has been performed from August 1, 2016 to June 30, 2018. We traced back 23 stroke patients, recruited during the above period, aged about 55 years with stroke duration \> 24 months . Intervention: 13 of them underwent 36 times of moderate-intensity continuous training (MICT) at 60% of peak oxygen consumption (VO2peak) for 30 mins, and 10 had high-intensity interval training (HIIT) at alternative 80% and 40% VO2peak with the same training times and duration. Outcome measures: VO2peak, cardiac output (CO), bilateral frontal cortex blood volume (∆\[THb\]), oxyhemoglobin (∆\[O2Hb\]) and deoxyhemoglobin (∆\[HHb\]), ventilation efficiency, serum brain-derived neurotrophic factor (BDNF) levels, cognitive and life quality questionnaire, percentage of neuroblastic cell bearing neurites (% neurites), and cell fluorescent staining were examined before and after interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
October 20, 2019
CompletedFirst Posted
Study publicly available on registry
October 22, 2019
CompletedOctober 22, 2019
July 1, 2019
1.9 years
October 20, 2019
October 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Peak cardiac output (CO)
Peak CO in millimeter per minute measured by non-invasive cardiac output measurement during exercise test before and after exercise training.
3-4 months (for 36 times of exercise training)
Peak exercise oxygen consumption (VO2peak)
VO2peak in ml/min/kg measured by cardiopulmonary function test before and after exercise training.
3-4 months (for 36 times of exercise training)
Oxygen uptake efficiency slope (OUES)
OUES in liter per minute/log(Liter per minute) derived from oxygen consumptions along time during exercise test before and after exercise training.
3-4 months (for 36 times of exercise training)
Ventilation/VCO2 ratio (Ve-VCO2)
Ve-VCO2, a number, derived from exhaled CO2 (ml/min/kg) versus ventilation (ml/min/kg) graph along time during exercise test before and after exercise training.
3-4 months (for 36 times of exercise training)
Differences of the brain tissue oxyhemoglobin (∆[O2Hb])
Differences oxyhemoglobin between involved and uninvolved frontal cortices in μM measured by two pairs of near infra-red spectroscopy (NIRS) probes before and after exercise training.
3-4 months (for 36 times of exercise training)
Differences of the brain tissue deoxygenation (∆[HHb])
Differences deoxyhemoglobin between involved and uninvolved frontal cortices in μM measured by two pairs of near infra-red spectroscopy (NIRS) probes before and after exercise training.
3-4 months (for 36 times of exercise training)
Differences of regional blood volume (∆[THb])
Differences regional blood volume between involved and uninvolved frontal cortices in μM measured by two pairs of near infra-red spectroscopy (NIRS) probes before and after exercise training.
3-4 months (for 36 times of exercise training)
Physical component score (PCS)
Physical role function obtained from short form 36 questionnaire (SF-36) before and after exercise training. The SF-36 consists of eight scaled scores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health), which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
3-4 months (for 36 times of exercise training)
Mental component score (MCS)
Mental health score obtained from short form 36 questionnaire (SF-36) before and after exercise training. The SF-36 consists of eight scaled scores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health), which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
3-4 months (for 36 times of exercise training)
Mini-mental status examination (MMSE)
a 30-point questionnaire that is used extensively to measure cognitive impairment before and after exercise training.
3-4 months (for 36 times of exercise training)
Brain-derived neurotrophic factor (BDNF)
The human BDNF (ng/mL), essential in maintaining neurogenesis and synaptic plasticity, capture antibody in a solid-phase sandwich, two-site enzyme linked immunoassay (ELISA) kit. The BDNF level was then determined by the microplate reader before and after exercise training.
3-4 months (for 36 times of exercise training)
Percentage of cell bearing neurites
A total of 100000 cells were plated overnight on 35-mm dishes coated with poly- DL-lysine. After serum starvation in DMEM containing 2% HS for 12-18 h, cells were treated with 50 ng/ml NGF for the indicated time. Morphological changes were observed using the Leica TCS SP8 confocal microscopy 7 days after cultured with patient sera before and after exercise training. Percentage of cells with neurites of at least one cell body diameter in length was determined in five independent fields of every plate.
3-4 months (for 36 times of exercise training)
Neuron images
Cells (100000) were inoculated in each well of the eight-chamber slide (Millicell EZ slide, Millipore Corp., Billerica, MA) and were incubated at the pre- and post-MICT or HIIT sera for 12h. Vivid staining of Mitotracker (Invitrogen corp., Carlsbad, CA) was used to observe mitochondria in neuroblastic cells treated with sera from the above different status. The cells were stained with primary rabbit monoclonal anti-⍺-tubulin antibodies (Cell Signaling Technology Inc., Boston, MA). Fluorescein isothiocyanate-conjugated AffiniPure Goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) was used as the secondary antibody. Nuclei were counterstained with mounting medium (Vector Laboratories Inc., Burlingame, CA) containing 40,6-diamidino-2-phenylindole. The stained cells were examined with a confocal microscopic examination (Leica TCS SP8, Leica Microsystems Inc., Buffalo Grove, IL).
3-4 months (for 36 times of exercise training)
Study Arms (1)
Pre- and Post- exercise training effects
EXPERIMENTALAll recruited subjects received aerobic exercise training (HIIT or MICT). VO2peak, cardiac output (CO), bilateral frontal cortex blood volume (∆\[THb\]), oxyhemoglobin (∆\[O2Hb\]) and deoxyhemoglobin (∆\[HHb\]), ventilation efficiency, serum brain-derived neurotrophic factor (BDNF) levels, cognitive and life quality questionnaire, percentage of neuroblastic cell bearing neurites (% neurites), and cell fluorescent staining were examined before and after interventions.
Interventions
All recruited subjects underwent 36 times of moderate-intensity continuous training (MICT) at 60% of peak oxygen consumption (VO2peak) for 30 mins, and 10or had high-intensity interval training (HIIT) at alternative 80% and 40% VO2peak with the same training times and duration.
Eligibility Criteria
You may qualify if:
- Stroke patients, diagnosed by the neurologist, with stable clinical status for greater than 3 months after conservative treatment or intervention were enrolled in the study.
- Mini-mental state examination (MMSE)\> 24
- No acute coronary syndrome
You may not qualify if:
- Unstable angina
- Systolic blood pressure\> 200 mmHg or diastolic blood pressure\> 110 mm Hg
- Symptomatic orthostatic hypotension
- Severe aortic stenosis (peak systolic pressure gradient\> 50 mmHg, or an aortic valve opening area\< 0.75 cm2)
- Inflammatory disease within recent 3 months
- Uncontrolled cardiac dysrhythmias
- Uncompensated heart failure
- Pericarditis or myocarditis within recent 3 months
- Embolic disease within recent 3 months
- ST segment displacement≥ 2 mm at rest
- Uncontrolled diabetes (blood glucose≥ 300 mg/dL or ≥ 250 mg/dL with ketone bodies).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Hsu CC, Fu TC, Huang SC, Chen CP, Wang JS. Increased serum brain-derived neurotrophic factor with high-intensity interval training in stroke patients: A randomized controlled trial. Ann Phys Rehabil Med. 2021 Jul;64(4):101385. doi: 10.1016/j.rehab.2020.03.010. Epub 2020 May 11.
PMID: 32344098DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2019
First Posted
October 22, 2019
Study Start
August 1, 2016
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
October 22, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share